Nicotine delivery from smoking bidis and an additive-free cigarette.

Plain-language guide to PMID 12521408 (2002): open-label randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID: 12521408
Journal: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Year: 2002
Study type: Randomized Controlled Trial
Authors: Malson JL et al. (4 authors)
DOI: 10.1080/1462220021000018498

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.

The present study was conducted to determine whether smoking bidis, an additive-free cigarette, and conventional cigarettes caused similar biochemical, physiological and subjective effects.

Why It Was Studied

This was an open-label, within-subject design.

In each session, subjects (n = 10) smoked a single cigarette: an unfiltered Natural American Spirit, an unfiltered Irie bidi, an unfiltered Sher bidi, or one of the participant's own brand.

Who Took Part

By PubMed's age tags, the people studied were adults, both men and women.

How the Study Was Run

In design terms this was a randomized and open-label study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Everyone knew when Therapeutic nicotine (patch, non-peptide) was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

The presentation of the cigarettes was randomized.

Before and up to 1 h after smoking, biochemical markers [plasma nicotine levels and exhaled carbon monoxide (CO)] and physiological effects of nicotine (heart rate and blood pressure) were measured.

What Was Measured

After smoking, subjects completed two standardized tests of cigarette liking and cigarette sensations.

Topics PubMed links to this paper include Carbon Dioxide, Nicotine, Personal Satisfaction, Smoking and Surveys and Questionnaires.

What This Means in Plain Language

The paper is a randomized and open-label study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2002 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Therapeutic nicotine (patch, non-peptide) in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.